British-Swedish pharmaceutical company
AstraZeneca ▸ Facts ▸ Comments ▸ News ▸ Videos
Credit: FRANCE 24 English Duration: 04:34Published
Boris Johnson pledges one billion vaccinations
Credit: ODN Duration: 01:30Published
Boris Johnson receives second Covid vaccine dose
Credit: PA - Press Association STUDIO Duration: 01:31Published
EU seeks huge fine in court over AstraZeneca vaccine delivery delays
Credit: euronews (in English) Duration: 02:20Published
Credit: FRANCE 24 English Duration: 03:52Published
Vaccine in numbers: UK passes 60m jabs milestone
Credit: PA - Press Association STUDIO Duration: 00:37Published
Coronavirus: Pfizer and AstraZeneca jabs effective against Indian variant
Credit: PA - Press Association STUDIO Duration: 01:18Published
Daily politics briefing: May 23
Credit: PA - Press Association STUDIO Duration: 00:47Published
Kenya's health minister: Africa 'must stop believing' world will help
Credit: Bleacher Report AOL Duration: 02:30Published
Biden announces US will share more vaccines globally
Credit: Bleacher Report AOL Duration: 02:12Published
Mixing Covid-19 vaccines 'could increase side effects'
Credit: Cover Video STUDIO Duration: 01:22Published
Vaccine in numbers: More than 18 million second jabs given
Credit: PA - Press Association STUDIO Duration: 00:37Published
European Union opts not to renew AstraZeneca vaccines contract after supply row
Credit: euronews (in English) Duration: 01:00Published
Taoiseach receives AstraZeneca vaccine
Credit: PA - Press Association STUDIO Duration: 00:30Published
Age threshold for alternative to AstraZeneca jab raised
Credit: PA - Press Association STUDIO Duration: 00:38Published
Under-40s in UK to get alternative Covid jab to AstraZeneca
Credit: ODN Duration: 01:00Published
Vaccine production is truly international collaboration in India: EAM
Credit: ANI Duration: 01:57Published
UK agreed to expand partnership on vaccines: MEA
Credit: ANI Duration: 01:13Published
Watch: Congress responds to Adar Poonawalla’s ‘being threatened’ charge
Credit: HT Digital Content Duration: 02:05Published
‘Will return to India in a few days’: Adar Poonawalla after alleged threat calls
Credit: HT Digital Content Duration: 01:50Published
‘Getting aggressive calls…’: Adar Poonawalla on Covid vaccine pressure in India
Credit: HT Digital Content Duration: 01:43Published
Europe's week: Vaccine passports, Brexit, Sofagate and AstraZeneca
Credit: Euronews English Duration: 07:00Published
You Might Like
Vietnam to receive 1 million doses of AstraZeneca vaccine weekly from July
AstraZeneca top expert backs India on widening Covishield dose gap
When should you take second dose of Covishield vaccine? AstraZeneca says THISAstraZeneca on Friday backed the idea of keeping a 12-16 weeks gap between the two doses of the Covishield vaccine.
AstraZeneca vaccine's chief investigator backs India's 12-16 week Covishield dose gap
AstraZeneca and EU both claim win as court rules on vaccine supply rowAstraZeneca and the EU have both claimed victory in a court ruling over the supply of COVID-19 vaccines.
Covishield produces more antibodies than Covaxin, finds studyCovishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufactured vaccine by Hyderabad-based Bharat Biotech in..
US to ease Covid vaccine input supply: Kamala Harris to PM ModiUS Vice-President Kamala Harris on Thursday spoke to PM Narendra Modi to brief him about the Biden administration’s new vaccine policy that will clear supply chains for AstraZeneca and Novavax..
Boris Johnson receives second dose of AstraZeneca COVID vaccineBoris Johnson has had his second dose of the AstraZeneca COVID vaccine.
UK government negotiating with AstraZeneca to secure South African variant vaccineThe UK government has begun negotiations with AstraZeneca to secure a "variant vaccine" that can tackle the South African variant, Health Secretary Matt Hancock has said.
US redirects vaccine manufacturing supplies allowing India to make additional 20 million Covid vaccine dosesThe US government on Friday redirected orders of critical vaccine manufacturing supplies, which will allow India to make over 20 million additional doses of AstraZeneca Covid-19 vaccines.
ICMR to examine effectiveness of AstraZeneca's Covishield and Bharat Biotech's Covaxin
Small number of people suffer stroke after AstraZeneca jab - as experts urge doctors to be alertDoctors have been told to look out for signs of stroke in patients who received the Oxford/AstraZeneca coronavirus jab after one person died and two others needed hospital treatment.
Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK studyTwo doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of Covid-19, first discovered in India, a new UK..
'It would be a disaster': Vaccine hesitancy in some African nations risks jabs going out of dateWhen the world-wide vaccine alliance, GAVI, announced that 132,000 AstraZeneca vaccines had been designated for South Sudan, doctors and health officials in this impoverished country were both..
3-month gap between doses improves immune response: AZ vax co-developerA three-month gap between two doses of the AstraZeneca vaccine, known in India as Covishield, improves the immune response against Covid-19, according to Andrew Pollard, co-developer of the vaccine and..
'Morally wrong' to offer COVID jabs to children while poorer nations suffer, says Oxford expertIt is "morally wrong" to offer coronavirus jabs to children in wealthy countries when people at greater risk in poorer nations remain unvaccinated, one of the scientists behind the Oxford-AstraZeneca..
Biggest AstraZeneca jab maker unlikely to resume exports 'for at least three months'The world's biggest maker of the AstraZeneca vaccine is unlikely to resume major exports until at least October as it prioritises doses for India's coronavirus crisis.
26 cases of blood clotting, bleeding due to AstraZeneca vaccine in India: Govt
Under-40s to be offered alternative to Oxford jab over blood clot fearsAll under-40s are to be offered an alternative to the Oxford/AstraZeneca coronavirus vaccine as a precaution.
US 'doing a lot for India' to meet Covid crisis: Joe BidenPresident Joe Biden has said that the US was "doing a lot for India" by sending it oxygen and materials to make anti-Covid-19 vaccines. Biden's spokesperson Jen Psaki said that the US government was..
Sweden plans to donate 1 million doses of AstraZeneca vaccines to IndiaSweden plans to donate 1 million doses of AstraZeneca vaccines to India via the UN-backed COVAX, an initiative devised to give countries access to coronavirus vaccines regardless of their wealth.
Serum Institute plans to start Covid vaccine production outside India: ReportThe Serum Institute of India, which manufactures the AstraZeneca Covid-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief..
5 million doses of COVID-19 vaccine Sputnik V in India by June, says Indian envoy to Russia Venkatesh VarmaNew Delhi: India is set to get 5 million doses of Russian COVID vaccine Sputnik V by June, even as the vaccine is set to be rolled in the country from May 1. Sputnik V is the third vaccine India has..
India's COVID crisis: US to redirect 20M doses of AstraZeneca vaccines, send raw material to make 5,00,000 dosesOver the weekend, the US announced that it will be diverting raw material to India for manufacturing of COVID-19 vaccines in the country.
US to share up to 60 million doses of AstraZeneca vaccine with the worldThe US will share up to 60 million doses of the AstraZeneca vaccine with the world, the White House has said.
EU Commission sues AstraZeneca over vaccine contractThe European Commission has launched legal action against AstraZeneca for not respecting a contract for the supply of COVID-19 vaccines.
EU takes legal action against AstraZeneca over vaccine supplyA legal case has been started by the European Commission against AstraZeneca over its "complete failure" to meet delivery and contractual agreements, Ireland's health minister has said.
How big is risk of clots from Covishield?The risk is extremely low, and the link between blood clots and the Oxford-AstraZeneca vaccine is still not 100% clear. Also, the clots can be treated if patients report them early.
UNICEF says AstraZeneca supply issues outside India resolved
Family of Italian woman who died after Oxford jab launch legal actionThe family of an Italian woman who died weeks after having the Oxford-AstraZeneca coronavirus vaccine have told Sky News they are taking legal action to establish whether the jab was to blame.
Risk of blood clot after COVID is eight times higher than after AstraZeneca jab - studyThe risk of developing a blood clot after having COVID-19 is eight times higher than after being given the Oxford-AstraZeneca vaccine, according to a study by Oxford University.
European Medicines Agency issues post-vax adverse-event alert for medicsThe safety committee of the European Medicines Agency (EMA) has asked those receiving the AstraZeneca vaccine (called Covishield in India) and medical professionals to look out for cases of unusual..
'It's been a massive achievement': Former AstraZeneca board member defends firm over vaccineA former AstraZeneca board member has told Sky News that she thinks the company has been unfairly criticised over its handling of the vaccine rollout.
India to review Covid-19 vaccines after blood clot warning: ReportA government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two Covid-19 vaccines being administered in India, a media report said..
Blood clot victim's sister 'very angry' but says everyone should have Oxford jabThe sister of a man who died from a blood clot after receiving the Oxford-AstraZeneca vaccine has said she is "very angry" but still "strongly" believes people should have the vaccine.
More than 700,000 doses of AstraZeneca jab 'flown from UK to Australia'More than 700,000 doses of the Oxford-AstraZeneca vaccine have been flown from the UK to Australia, it has been reported.
Oxford jab scientist set for £20m windfall in 'New York flotation'The scientist who led the development of the Oxford University-AstraZeneca coronavirus vaccine is on course for a payday of more than £20m through a stock market listing, according to reports.
'Full speed ahead' for vaccine rollout - but 18 to 29-year-olds to be offered alternative to Oxford jabBoris Johnson has said the roadmap out of lockdown will not be affected by the decision to offer 18 to 29-year-olds an alternative to the Oxford-AstraZeneca vaccine.
AstraZeneca sends legal notice to SII over delays in vaccine supply
What is the AstraZeneca blood clot risk and how does it compare?The use of the Oxford-AstraZeneca vaccine in those under 30 is to be limited due to concerns over blood clots - but what exactly is the risk and how does it compare?
Serum Institute asks government for $403 million to boost AstraZeneca vaccine outputThe Serum Institute of India has asked the government for a grant of 30 billion rupees ($402.97 million) to increase its capacity to make AstraZeneca's Covid-19 vaccine. It is seeking the money to ramp..
'Unusual blood clots' should be listed as 'very rare' side effect of Oxford vaccine, EU regulator saysThe European medicines regulator says that "unusual blood clots" should be listed as "very rare" side-effects of the Oxford-AstraZeneca COVID vaccine.
Britons aged 18-29 to be offered alternative to Oxford jabBritons aged 18-29 will be offered an alternative to the Oxford-AstraZeneca vaccine where available, government advisors have decided.
Does the AstraZeneca vaccine still pass the risk-benefit analysis for young people?The greater the risk of a disease, the greater the risk doctors would be prepared to take to prevent it.
Everything you need to know about the Moderna vaccineThe Moderna coronavirus vaccine is the third jab to be rolled out in the UK, alongside the Pfizer/BioNTech and Oxford University-AstraZeneca jabs.
UK trial of Oxford COVID jab on children paused as regulator probes blood clots in adultsA trial of the Oxford-AstraZeneca COVID vaccine on children in the UK has been paused while the medicines regulator investigates a possible link between the jab and rare blood clots in adults.
EU medical regulator's chief: 'Increasingly difficult' to say no link between Oxford jab and rare blood clotsThe head of the European Medicines Agency (EMA) has said it is "increasingly difficult" to say there is "no cause and effect relationship" between the Oxford-AstraZeneca jab and "rare cases of unusual..